Masaki Hiramoto

Tokyo Medical University — Japan

Medicine · Health Sciences

29h-index3.6kcitations103works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autophagy in Disease and Therapy(16), RNA modifications and cancer(15), Lung Cancer Treatments and Mutations(11), Lung Cancer Diagnosis and Treatment(9), Hematopoietic Stem Cell Transplantation(8)

Publications103 total

Single-housing–induced islet epigenomic changes are related to polymorphisms in diabetic KK mice
Life Science Alliance·2024· 1 citedOpen Access
Clarithromycin overcomes stromal cell-mediated drug resistance against proteasome inhibitors in myeloma cells via autophagy flux blockage leading to high NOXA expression
PLoS ONE·2023· 2 citedOpen Access
Glucocorticoid receptor-NECAB1 axis can negatively regulate insulin secretion in pancreatic β-cells
Scientific Reports·2023· 6 citedOpen Access
Supplementary Figures 1 - 5 from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Supplementary Materials and Methods from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Supplementary Table Legends from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Supplementary Tables 1 - 2 from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Supplementary Tables 1 - 2 from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Supplementary Table Legends from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Supplementary Figure Legends from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Data from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Supplementary Figure Legends from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Supplementary Materials and Methods from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Supplementary Figures 1 - 5 from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Data from Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
2023Open Access
Azithromycin, a potent autophagy inhibitor for cancer therapy, perturbs cytoskeletal protein dynamics
British Journal of Cancer·2023· 24 citedOpen Access
Ricolinostat enhances adavosertib‑induced mitotic catastrophe in TP53‑mutated head and neck squamous cell carcinoma cells
International Journal of Oncology·2022· 24 citedOpen Access
Lysosome‑targeted drug combination induces multiple organelle dysfunctions and non‑canonical death in pancreatic cancer cells
Oncology Reports·2021· 14 citedOpen Access
Targeted disruption of GAK stagnates autophagic flux by disturbing lysosomal dynamics
International Journal of Molecular Medicine·2021· 17 citedOpen Access
Induction of synergistic non‑apoptotic cell death by simultaneously targeting proteasomes with bortezomib and histone deacetylase 6 with ricolinostat in head and neck tumor cells
Oncology Letters·2021· 11 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Keisuke Miyazawa(19), Hiroshi Handa(16), Shin Aizawa(14), Shota Moriya(13), Hiromi Kazama(12), Naoharu Takano(11), Hirotsugu Hino(9), Hiroko Kokuba(9), Kazuki Yasuda(8), Hirotoshi Tanaka(7), Takao Nammo(6), Noriaki Shimizu(5), H Hoshi(5), Kiyoaki Tsukahara(5), Isao Makino(4), Daisuke Shima(4), Yutaka Kawakami(4), Haruhide Udagawa(4), Ayako Hirota(4), Takeshi Imai(4)